High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1–actin Complex as a New Potential Target for Therapy

Although the eukaryotic elongation factor eEF1A1 plays a role in various tumours, there is little information on its prognosis/therapeutic value in prostate carcinoma. In high-grade and castration-resistant prostate carcinoma (CRPC), the identification of novel therapeutic markers/targets remains a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosutti, Alessandra, Dapas, Barbara, Grassi, Gabriele, Bussani, Rossana, Zanconati, Fabrizio, Giudici, Fabiola, Bottin, Cristina, Pavan, Nicola, Trombetta, Carlo, Scaggiante, Bruna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027132/
https://www.ncbi.nlm.nih.gov/pubmed/35456960
http://dx.doi.org/10.3390/ijms23084143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027132/
https://www.ncbi.nlm.nih.gov/pubmed/35456960
http://dx.doi.org/10.3390/ijms23084143

Ejemplares similares